Cynthia E Hawkins Selected Research

Cynthia E Hawkins Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 07/2005
13	Medulloblastoma 01/2021 - 07/2005
6	Brain Neoplasms (Brain Tumor) 01/2019 - 12/2009
5	Glioma (Gliomas) 01/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
3	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 02/2009
3	Ependymoma 01/2016 - 07/2010
2	Turcot syndrome 01/2021 - 01/2016
2	Diffuse Intrinsic Pontine Glioma 01/2018 - 01/2016
2	Primitive Neuroectodermal Tumors (PNET) 08/2014 - 12/2009
2	Epilepsy (Aura) 03/2012 - 07/2008
1	Microsatellite Instability 01/2021
1	Carcinogenesis 12/2020
1	Circulating Neoplastic Cells 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2017
1	Neuroblastoma 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Splenomegaly 11/2013
1	Hemorrhage 11/2013
1	Thrombosis (Thrombus) 11/2013
1	Chromothripsis 08/2012
1	Cap Myopathy 04/2010
1	Muscle Hypotonia (Hypotonia) 01/2008
1	Brain Diseases (Brain Disorder) 01/2008
1	Stroke (Strokes) 01/2008
1	Coma (Comas) 01/2008
1	Muscular Diseases (Myopathy) 01/2008
1	Cognitive Dysfunction 01/2008
1	Cardiomyopathies (Cardiomyopathy) 01/2008
1	Seizures (Absence Seizure) 01/2008
1	Brain Contusion 09/2007
1	Anemia 09/2007
1	Muscle Weakness 08/2006

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 02/2009
3	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2011
3	Formaldehyde (Formol)FDA Link 01/2016 - 04/2011
2	Immune Checkpoint InhibitorsIBA 12/2020 - 01/2016
2	dipinacoline glutamateIBA 01/2018 - 01/2016
2	Genetic Markers (Genetic Marker)IBA 05/2017 - 06/2015
2	ParaffinIBA 01/2016 - 03/2014
1	acetyl- glycyl- valyl- allo- isoleucyl- seryl- glutaminyl- isoleucyl- arginyl- prolyl- cysteinamideIBA 01/2021
1	PeptidomimeticsIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	Exonucleases (3' 5' Exonuclease)IBA 12/2020
1	CateninsIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Interleukin-13IBA 01/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2016
1	2- O- (6- O- glycero- manno- heptopyranosyl- glucopyranosyl)glucopyranoseIBA 01/2016
1	Histones (Histone)IBA 01/2016
1	LithiumIBA 12/2014
1	Radiation-Sensitizing AgentsIBA 12/2014
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2014
1	von Willebrand FactorIBA 11/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2013
1	Platelet Factor 4IBA 11/2013
1	P-SelectinIBA 11/2013
1	Actins (F Actin)IBA 04/2010
1	FilaminsIBA 07/2008
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2008
1	Oxygen (Dioxygen)IBA 09/2007
1	DystrophinIBA 08/2006

Therapy/Procedure

17	Therapeutics 01/2021 - 11/2005
3	Drug Therapy (Chemotherapy) 10/2016 - 08/2012
2	Immunotherapy 01/2021 - 12/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2018
1	Image-Guided Radiotherapy 01/2016
1	Cytoreduction Surgical Procedures 01/2016
1	Radiotherapy 01/2016
1	Chemoradiotherapy 01/2016
1	Craniospinal Irradiation 01/2016
1	Lasers (Laser) 11/2013
1	Re-Irradiation 08/2012
1	Hemodilution 09/2007